Teoxane Teosyal® PureSense Redensity 2 (2x1ml)

Description

Teoxane Teosyal PureSense Redensity 2 (2x1ml)

Teosyal® PureSense Redensity 2 is a CE-marked, injectable hyaluronic acid (HA) dermal filler specifically formulated for use in delicate facial regions such as the periorbital area and tear troughs. Developed by Teoxane Laboratories (Switzerland), Redensity 2 combines cross-linked and non-cross-linked HA at 15 mg/ml with an advanced nutrient complex of 8 amino acids, 3 antioxidants, 2 minerals, and vitamin B6 to support tissue health and dermal function. All formulations contain lidocaine 0.3 % to enhance patient comfort during injection. Redensity 2’s viscoelastic gel is tailored for superficial to deep dermal placement where fine lines, under-eye hollows, and mild periorbital dark circles persist, delivering temporary structural support and hydration that typically lasts up to 9–12 months.

What Teosyal® PureSense Redensity 2 Is Similar To

In clinical category and mechanism, Teosyal® PureSense Redensity 2 is similar to tear trough-specific hyaluronic acid fillers like Restylane® Differences and Belotero® Balance / Soft. All of these products provide temporary dermal volumisation and hydration by integrating HA into tissue planes with tailored viscoelastic properties for fine-line and contour correction. Redensity 2’s unique nutrient complex is designed for delicate zones and may offer supplementary antioxidative and amino-acid support not present in simple HA gels. As with most under-eye fillers, the depth of injection and product choice should align with anatomical requirements to minimise the risk of oedema or Tyndall effect. Duration of effect for these products generally ranges from 6–12 months, depending on filler cross-linking, gel characteristics, and individual patient factors. This comparison is provided for clinical orientation only and does not imply interchangeability.

Treatment Areas / Indications

• Tear troughs (infraorbital hollows)

• Periorbital under-eye region

• Fine superficial wrinkles around the eye area

• Mild under-eye dark circles with volume loss

• Treatment areas per distributor product info (clinical use by trained professionals)

Usage / Administration (IFU-Only)

Direct injection parameters not publicly published in full IFU — the following reflects manufacturer indications where available; if not specified by IFU, noted as such.

• Injection depth: Superficial to deep dermis or supra-periosteal plane in tear trough area

• Injection technique: Microinjections by qualified medical professionals only

• Needle gauge provided: 30 G × ½″ sterile needles included in packaging

• Volume per site: Not provided by manufacturer in public product data

• Frequency / sessions: Not provided by manufacturer in public product data

• Professional use: Administered only by trained medical personnel under aseptic conditions

Some practitioners report supra-periosteal placement in tear troughs as a widely adopted method; this is not part of official manufacturer IFU.

Ingredient List

• Hyaluronic Acid (HA): 15 mg/ml (cross-linked + non-cross-linked)

• Lidocaine Hydrochloride: 0.3 % for injection comfort

• Amino acids: Glycine, Lysine, Threonine, Proline, Isoleucine, Leucine, Valine, Arginine

• Antioxidants: Glutathione, N-acetyl-L-cysteine, Alpha-lipoic acid

• Minerals: Zinc, Copper

• Vitamin: B6 (Pyridoxine)

Presentation & Longevity

• Packaging: 2 × 1 ml prefilled syringes, plus 2–4 × 30 G × ½″ needles and traceability labels

• Shelf life: Not provided by manufacturer public documents

• Longevity: Effects generally last up to 9–12 months, subject to patient factors

Safety Notes / Contraindications

• Contraindicated in patients with hypersensitivity to any component, including HA or lidocaine

• Avoid in areas of active skin inflammation, infection, or compromised tissue

• Not intended for deep malar bags or severe tear trough depressions

• Requires professional assessment; injection risks include temporary swelling, bruising, redness, or tenderness

Follow full contraindications in the official IFU.

Regulatory Status

• CE-marked Class III medical device (EU MDR) — meeting regulatory standards for safety and performance

• Regulatory classification not specified in public documentation; verify on product pack or official IFU

FAQ

1. What is Teosyal® PureSense Redensity 2?
Teosyal® PureSense Redensity 2 is a professional hyaluronic acid dermal filler designed for treating under-eye hollows, fine lines, and mild dark circles. It combines HA with an advanced nutrient complex to support tissue hydration and structure in delicate periorbital areas. It includes lidocaine to reduce injection discomfort during procedures performed by trained professionals.

2. How does it work?
This filler works by physically restoring volume and hydrating the dermis via HA, which binds water within tissues. The added amino acids, antioxidants, minerals, and vitamin B6 contribute to microenvironment support but do not alter the mechanical volume-restoring function of HA.

3. How long do results last?
Clinical data from distributors and product literature indicate effects usually persist up to 9–12 months, though this varies with metabolism, technique, and patient lifestyle factors.

4. Is it safe?
When administered by trained clinicians following aseptic technique, Redensity 2 is generally safe. Common, usually transient events include swelling, bruising, redness, or tenderness at the injection site. Contraindications include active infection or hypersensitivity to any component.

5. How does it compare to other under-eye fillers?
Like other under-eye fillers (e.g., Restylane®) it provides temporary volume support. Its nutrient complex aims to support delicate tissue environments, but injection depth and practitioner expertise remain key determinants of outcomes. This is not medical advice; injector consultation is essential.